The adoption of a truncated version of dystrophin as a possible treatment for DMD is based on a Becker muscular dystrophy patient who remained ambulatory for seven decades despite a deletion of nearly half his DMD gene.26 This evidence concerns the gene DMD and Duchenne muscular dystrophy.